Related Experiment Videos
Renal disease in cardiovascular disorders: an underrecognized problem
Alain Baumelou1, Eric Bruckert, Corinne Bagnis
1Department of Nephrology, Hôpital Pitié-Salpêtrière, Paris, France.
American Journal of Nephrology
|March 24, 2005
Summary
Chronic kidney disease (CKD) is a growing health issue, often underrecognized in cardiovascular patients. Early detection through glomerular filtration rate (GFR) estimates and microalbuminuria screening is crucial for managing renal and cardiovascular risks.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Chronic kidney disease (CKD) is a significant and escalating global health concern.
- CKD is underrecognized in cardiovascular disease (CVD) patients, despite its prevalence and impact.
- Minor renal function impairments are common in CVD and predict cardiovascular events.
Purpose of the Study:
- To highlight the underrecognized role of renal disease in cardiovascular patients.
- To emphasize the predictive value of renal disease markers for cardiovascular morbidity and mortality.
- To advocate for improved recognition and management of CKD in at-risk populations.
Main Methods:
- Review of evidence linking renal function markers (GFR, microalbuminuria) to cardiovascular outcomes.
- Analysis of the predictive power of renal disease markers compared to conventional risk factors.
- Discussion of screening protocols and risk factor control for renal protection.
Main Results:
- Markers of renal disease, including microalbuminuria, are prevalent in cardiovascular disease states.
- Renal disease markers are as predictive of morbidity and mortality as traditional risk factors in patients with hypertension, diabetes, and stroke.
- Current clinical practice shows poor recognition and management of renal disease in at-risk individuals.
Conclusions:
- Even mild renal dysfunction significantly impacts cardiovascular outcomes.
- Microalbuminuria may indicate systemic vascular disease, not solely kidney dysfunction.
- Improved screening using GFR estimates and better risk factor management are essential for renal and cardiovascular protection.